CytomX Therapeutics, Inc.
CTMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $32 | -$1 | -$99 | -$84 |
| Dep. & Amort. | $2 | $2 | $6 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $0 | $0 | $13 |
| Change in WC | -$126 | -$63 | -$31 | -$55 |
| Other Non-Cash | -$1 | $5 | $13 | $3 |
| Operating Cash Flow | -$86 | -$56 | -$111 | -$119 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | -$24 |
| Inv. Purchases | -$155 | -$425 | $0 | -$100 |
| Inv. Sales/Matur. | $256 | $275 | $100 | $124 |
| Other Inv. Act. | $0 | $0 | $0 | $24 |
| Investing Cash Flow | $100 | -$151 | $98 | $22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $30 | $1 | $108 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $3 |
| Financing Cash Flow | $8 | $30 | $1 | $110 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $21 | -$176 | -$12 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18 | $194 | $206 | $193 |
| End Cash | $39 | $17 | $194 | $206 |
| Free Cash Flow | -$87 | -$57 | -$113 | -$121 |